Cannabis Financial Statements From 2010 to 2024

CBGL Stock  USD 0.0001  0.00  0.00%   
Cannabis Global financial statements provide useful quarterly and yearly information to potential Cannabis Global investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cannabis Global financial statements helps investors assess Cannabis Global's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cannabis Global's valuation are summarized below:
Cannabis Global does not presently have any fundamental signals for analysis.
Check Cannabis Global financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cannabis Global's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cannabis financial statements analysis is a perfect complement when working with Cannabis Global Valuation or Volatility modules.
  
This module can also supplement various Cannabis Global Technical models . Check out the analysis of Cannabis Global Correlation against competitors.

Cannabis Global Company Operating Margin Analysis

Cannabis Global's Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.

Operating Margin

 = 

Operating Income

Revenue

X

100

More About Operating Margin | All Equity Analysis

Current Cannabis Global Operating Margin

    
  (0.85) %  
Most of Cannabis Global's fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannabis Global is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
Competition

Based on the recorded statements, Cannabis Global has an Operating Margin of -0.8529%. This is 97.57% lower than that of the Healthcare sector and significantly lower than that of the Drug Manufacturers—Specialty & Generic industry. The operating margin for all United States stocks is 84.52% lower than that of the firm.

Cannabis Global Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cannabis Global's current stock value. Our valuation model uses many indicators to compare Cannabis Global value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannabis Global competition to find correlations between indicators driving Cannabis Global's intrinsic value. More Info.
Cannabis Global is rated third in return on equity category among its peers. It is rated fourth in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cannabis Global's earnings, one of the primary drivers of an investment's value.

About Cannabis Global Financial Statements

Cannabis Global investors utilize fundamental indicators, such as revenue or net income, to predict how Cannabis Pink Sheet might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Cannabis Global, Inc. focuses on the creating and commercialization of engineered technologies to deliver hemp extracts and cannabinoids to the human body. Cannabis Global, Inc. was incorporated in 2005 and is headquartered in Los Angeles, California. Cannabis Global operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 3 people.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

Other Information on Investing in Cannabis Pink Sheet

Cannabis Global financial ratios help investors to determine whether Cannabis Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannabis with respect to the benefits of owning Cannabis Global security.